Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 11, 2014

 

 

 

Commission

File Number

  

Exact name of registrant as specified in its charter,

principal office and address and telephone number

  

State of incorporation

or organization

   

I.R.S. Employer

Identification No.

000-55075  

Actavis plc

1 Grand Canal Square,

Docklands Dublin 2, Ireland

(862) 261-7000

   Ireland    98-1114402
333-199019  

Warner Chilcott Limited

Cannon’s Court 22

Victoria Street

Hamilton HM 12

Bermuda

(441) 295-2244

   Bermuda    98-0496358

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01. Other Events.

On December 11, 2014, Actavis plc (the “Company”) issued a press release confirming that Judge Robert Sweet of the United States District Court for the Southern District of New York has announced an intent to issue a preliminary injunction apparently requiring the Company to continue distribution of NAMENDA® (memantine HCl) immediate-release tablets. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Warner Chilcott Limited is a consolidated subsidiary of Actavis plc.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits.

 

Exhibit

No.

   

Description

99.1    Press Release dated December 11, 2014.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 11, 2014    

ACTAVIS plc

Warner Chilcott Limited

    By:  

/s/ A. Robert D. Bailey

    Name:   A. Robert D. Bailey
    Title:   Chief Legal Officer and Secretary